e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
de Torres J. P., Cordoba-Lanus E., Lopez-Aguilar C., Muros de Fuentes M., Montejo de Garcin... A., Aguirre-Jaime A., Celli B. R., Casanova C.
Source:
Eur Respir J 2006; 27: 902-907
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
de Torres J. P., Cordoba-Lanus E., Lopez-Aguilar C., Muros de Fuentes M., Montejo de Garcin... A., Aguirre-Jaime A., Celli B. R., Casanova C.. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006; 27: 902-907
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 363s
Year: 2007
Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Body composition and plasma levels of inflammatory biomarkers in COPD
Source: Eur Respir J 2010; 36: 1027-1033
Year: 2010
Genetically elevated C-reactive protein and chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Environmental and genetic risk factors for asthma and COPD
Year: 2009
Clinical value of C-reactive protein in severe acute exacerbations of COPD
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
The importance of C-reactive protein in patients with acute exacerbation of severe COPD
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
C-reactive protein and serum amyloid A overexpression in lung tissues of chronic obstructive pulmonary disease patients
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?
Source: Eur Respir J 2008; 32: 1451-1457
Year: 2008
Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
C-reactive protein in pulmonary tuberculosis-correlation with extent and severity of the disease
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Coexisting chronic diseases in COPD – cause of elevated level of C-reactive protein?
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020
Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept